Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
NCT00180817 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2022-08-08
Summary
This study is being done to see if there are any long term health related issues in women with APA and recurrent miscarriages.
Conditions
- Antiphospholipid Syndrome
Sponsors & Collaborators
-
Imperial College London
lead OTHER
Principal Investigators
-
Lesley Regan · Imperial College London
-
Raj Rai, MRCOG · Imperial College London
-
Winnie Lo · St. Mary's NHS Trust, London
-
Preeti Jindal, MRCOG · St. Mary's NHS Trust, London
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-09-30
- Primary Completion
- 2005-08-31
- Completion
- 2005-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Antiphospholipid Antibodies and Fetal Growth Restriction
NCT01538134 ·Status: UNKNOWN
-
Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death, According to Their Thrombophilia Status, With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome (oAPS)
NCT03969498 ·Status: COMPLETED
-
On Pregnancy After Losses - OPAL Study
NCT05167812 ·Status: NOT_YET_RECRUITING
-
Neutrophil Extracellular Traps Mediate Antiphospholipid Antibody-induced Pregnancy Loss
NCT03735108 ·Status: UNKNOWN
-
Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors
NCT05557201 ·Status: RECRUITING
-
Obstetric Antiphospholipid Antibody Syndrome : Contribution of the Evaluation of ADAMTS13 Made at the Diagnosis of Pregnancy on Evaluation the Risk of Pre-eclampsia
NCT04319341 ·Status: COMPLETED
-
Establish the Referenc Range of Antiphospholipid Antibody in Healthy Preganany Women
NCT05883189 ·Status: UNKNOWN
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
NCT02990403 ·Status: UNKNOWN ·Phase: PHASE4
-
Ocular Findings in Women With Primary Antiphospholipid Syndrome
NCT03459508 ·Status: COMPLETED
-
Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia
NCT02699437 ·Status: COMPLETED
-
Placental Pathology and Inflammatory Factor Analysis of OAPS
NCT05378516 ·Status: UNKNOWN
-
New Biological Tests in Patients With Antiphospholipid Antibodies
NCT03890601 ·Status: RECRUITING
-
Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths
NCT03601338 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome
NCT05786235 ·Status: RECRUITING
-
Use of Platelet Indices for Prediction of Recurrent Miscarriage
NCT03710226 ·Status: COMPLETED
-
Comparative Prevalence of Psychiatric Manifestations in Purely Obstetrical Antiphospholipid Syndrome
NCT01649479 ·Status: TERMINATED ·Phase: NA
-
Fibroids and the Risk of Miscarriage: a Prospective Observational Study in an Early Pregnancy Population
NCT06986616 ·Status: COMPLETED
-
Risk Factors of Ectopic Pregnancy
NCT00194207 ·Status: COMPLETED
-
Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome
NCT01661439 ·Status: UNKNOWN
-
Comprehensive Assessment of Risks for Miscarriage.
NCT04456660 ·Status: RECRUITING
-
Establishment of Special Disease Cohort for RPLand Study of Impact Mechanism of Early Embryo Development
NCT05186207 ·Status: UNKNOWN
-
Study on Retroplacental Hematomas in Finistère
NCT04168606 ·Status: COMPLETED
-
The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase(MTHFR) Gene Polymorphisms as Risk Factors for Recurrent Miscarriage
NCT03209063 ·Status: UNKNOWN
-
The Clinical Features and Pregnancy Outcomes of CTD Patients
NCT04918524 ·Status: RECRUITING